MRZM

Marizyme (QB) (MRZM)

Marizyme Inc (QB)

Von:

Regulatory News

Text Search:

Sortieren nach:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:MRZM

1 2 3 4 5 6 Next >>

Datum	Zeit	Quelle	Überschrift	Symbol	Firma
15/05/2024	22h05	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:MRZM	Marizyme Inc (QB)
13/05/2024	22h50	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:MRZM	Marizyme Inc (QB)
06/05/2024	23h00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
06/02/2024	22h15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:MRZM	Marizyme Inc (QB)
06/02/2024	14h55	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
29/12/2023	23h15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:MRZM	Marizyme Inc (QB)
29/12/2023	02h06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:MRZM	Marizyme Inc (QB)
28/12/2023	12h02	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
22/11/2023	22h36	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:MRZM	Marizyme Inc (QB)
21/11/2023	22h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
16/11/2023	12h08	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:MRZM	Marizyme Inc (QB)
14/11/2023	22h27	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:MRZM	Marizyme Inc (QB)
24/10/2023	22h15	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:MRZM	Marizyme Inc (QB)
24/10/2023	15h08	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
23/10/2023	15h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
18/10/2023	06h15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	USOTC:MRZM	Marizyme Inc (QB)
17/10/2023	23h10	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	USOTC:MRZM	Marizyme Inc (QB)
06/10/2023	15h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
04/10/2023	22h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
08/09/2023	16h22	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:MRZM	Marizyme Inc (QB)
07/09/2023	23h12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:MRZM	Marizyme Inc (QB)
05/09/2023	22h15	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
18/08/2023	22h05	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	USOTC:MRZM	Marizyme Inc (QB)
15/08/2023	22h15	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	USOTC:MRZM	Marizyme Inc (QB)
31/07/2023	14h59	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
31/07/2023	14h57	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	USOTC:MRZM	Marizyme Inc (QB)
18/07/2023	22h59	Edgar (US Regulatory)	Form S-1 - General form for registration of securities under the Securities Act of 1933	USOTC:MRZM	Marizyme Inc (QB)
12/07/2023	22h26	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:MRZM	Marizyme Inc (QB)
12/07/2023	22h00	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:MRZM	Marizyme Inc (QB)
23/06/2023	22h55	Edgar (US Regulatory)	Additional Proxy Soliciting Materials (definitive) (defa14a)	USOTC:MRZM	Marizyme Inc (QB)